Mupirocin is a prescription drug. It comes as a topical ointment, topical cream, and nasal ointment. Available for Android and iOS devices. Stopping the medication too early may result in a return of the infection.Tell your doctor if your condition does not get better in 3 to 5 days.Although uncommon, mild burning or stinging after using this medication may occur. Systemic absorption of mupirocin through intact human skin is minimal following topical administration of Mupirocin Cream The estimated background risk of major birth defects and miscarriage for the indicated population is unknown. How to use Bactroban 2 % Topical Ointment. In case of accidental contact, rinse well with water.In the event of a sensitization or severe local irritation from Mupirocin Cream, usage should be discontinued, and appropriate alternative therapy for the infection instituted.If CDAD is suspected or confirmed, ongoing antibacterial drug use not directed against As with other antibacterial products, prolonged use of Mupirocin Cream may result in overgrowth of nonsusceptible microorganisms, including fungi Mupirocin Cream is not formulated for use on mucosal surfaces. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.Things to remember when you fill your prescription.WebMD does not provide medical advice, diagnosis or treatment.This survey is being conducted by the WebMD marketing sciences department.All information will be used in a manner consistent with the WebMD Mupirocin calcium (Bactroban, C 52 H 86 CaO 18 .2H 2 O, MW 1075.34) has a narrow spectrum of activity, primarily against gram-positive bacteria. The following adverse reactions were reported by at least 1% of subjects in connection with the use of Mupirocin Cream in clinical trials: headache (1.7%), rash (1.1%), and nausea (1.1%).Other adverse reactions which occurred in less than 1% of subjects were: abdominal pain, burning at application site, cellulitis, dermatitis, dizziness, pruritus, secondary wound infection, and ulcerative stomatitis.In a supportive trial in the treatment of secondarily infected eczema, 82 subjects were treated with Mupirocin Cream. You may report side effects to Health Canada at 1-866-234-2345.This medicine may be harmful if swallowed. Subjects were randomized to either 10 days of topical Mupirocin Cream 3 times daily or 10 days of oral cephalexin (250 mg 4 times daily for subjects greater than 40 kg or 25 mg per kg per day oral suspension in 4 divided doses for subjects less than or equal to 40 kg). If it is near the time of the next dose, skip the missed dose. Chemically, it is (αE,2S,3R,4R,5S)-5- [(2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl]tetrahydro-3,4-dihydroxy-β-methyl-2H-pyran-2-crotonic acid, ester with 9-hydroxynonanoic acid, calcium salt (2:1), dihydrate.Each gram of Mupirocin Cream contains 20 mg (2% w/w) of mupirocin equivalent to 21.5 mg (2.15% w/w) of mupirocin calcium. Clinical efficacy at follow-up (7 to 12 days post-therapy) in the per-protocol populations was 97.7% (43 of 44) for Mupirocin Cream and 93.9% (46 of 49) for cephalexin.Mupirocin Cream is a white cream that contains 20 mg (2% w/w) of mupirocin per gram in an oil- and water-based emulsion.Mupirocin Cream USP, 2% is supplied in 15-gram (NDC 51672-1370-1) and 30-gram (NDC 51672-1370-2) tubes.Advise the patient to administer Mupirocin Cream as follows:Mfd. Continue to use it for the full time prescribed, even if symptoms disappear after a few days. High-level plasmid-mediated resistance (MIC ≥512 mcg/mL) has been reported in increasing numbers of isolates of Due to its mode of action, mupirocin does not demonstrate cross resistance with other classes of antimicrobial agents.Mupirocin has been shown to be active against susceptible isolates of High-level mupirocin resistance (≥512 mcg/mL) may be determined using standard disk diffusion or broth microdilution tests.Long-term studies in animals to evaluate carcinogenic potential of mupirocin calcium have not been conducted.Results of the following studies performed with mupirocin calcium or mupirocin sodium In a fertility/reproductive performance study (with dosing through lactation), mupirocin administered subcutaneously to male and female rats at doses up to 100 mg per kg per day which is 14 times the human topical dose (approximately 60 mg mupirocin per day) based on calculations of dose divided by the entire body surface area, did not result in impaired fertility or impaired reproductive performance attributable to mupirocin.The efficacy of topical Mupirocin Cream for the treatment of secondarily infected traumatic skin lesions (e.g., lacerations, sutured wounds, and abrasions not more than 10 cm in length or 100 cmThere were 93 pediatric subjects aged 2 weeks to 16 years enrolled per protocol in the secondarily infected skin lesion trials, although only 3 were younger than 2 years of age in the population treated with Mupirocin Cream.